Based on response to initial therapy, dosage can be increased after a 2 to 4 week interval. Adjust the dosing based on effectiveness and tolerability. Maximum recommended daily dose of teneligliptin is 40 mg and metformin is 2000 mg. TENEBLU-M and TENEBLU-M Forte Tablets should be administered with food to reduce the gastrointestinal (GI) side effects associated with metformin. The tablets should be swallowed whole with liquid and not to be split, crushed, or chewed. Or, as prescribed by the Physician.
| COMPOSITION | |
|---|---|
| TENEBLU-M Tablets | |
| Each uncoated bilayered tablet contains: | |
| Teneligliptin Hydrobromide Hydrate equivalent to Teneligliptin | 20 mg |
| Metformin Hydrochloride IP (in sustained release form) | 500 mg |
| TENEBLU-M Forte Tablets | |
| Each Uncoated Tablet Contains: | |
| Teneligliptin Hydrobromide Hydrate equivalent to Teneligliptin | 20 mg |
| Metformin Hydrochloride IP (in sustained release form) | 1000 mg |
| INDICATIONS | |
| TENEBLU-M and TENEBLU-M Forte Tablets are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with either metformin or teneligliptin monotherapy is not adequate. | |
| DOSAGE AND ADMINISTRATION | |
| For oral administration in adults.: TENEBLU-M Tablets: Usual recommended dose is 1 tablet once daily in type 2 diabetic patients. TENEBLU-M Forte Tablets: Usual recommended dose is 1 tablet once daily, preferably in overweight or obese type 2 diabetic patients. |
|
| HOW SUPPLIED | |
| 15 Tablets per strip. | |
